Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Brian Lowes"'
Autor:
Arif Albulushi, Desmond Boakye Tanoh, Ahmed Almustafa, Nadya Al Matrooshi, Ronald Zolty, Brian Lowes
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-18 (2024)
Abstract Background Heart failure with preserved ejection fraction (HFpEF) is common in type 2 diabetes mellitus (T2D), leading to high morbidity and mortality. Managing HFpEF in diabetic patients is challenging with limited treatments. Sodium-glucos
Externí odkaz:
https://doaj.org/article/ad3d0b56410c49c29f17f77dcdea7fc7
Autor:
Hanyu Ni, Elizabeth Jordan, Daniel D. Kinnamon, Jinwen Cao, Garrie J. Haas, Mark Hofmeyer, Evan Kransdorf, Gregory A. Ewald, Alanna A. Morris, Anjali Owens, Brian Lowes, Douglas Stoller, W.H. Wilson Tang, Sonia Garg, Barry H. Trachtenberg, Palak Shah, Salpy V. Pamboukian, Nancy K. Sweitzer, Matthew T. Wheeler, Jane E. Wilcox, Stuart Katz, Stephen Pan, Javier Jimenez, Daniel P. Fishbein, Frank Smart, Jessica Wang, Stephen S. Gottlieb, Daniel P. Judge, Charles K. Moore, Gordon S. Huggins, Ray E. Hershberger
Publikováno v:
Journal of the American College of Cardiology. 81:2059-2071
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85ed9eaa5e043cef5ad4a75d21bac488
https://doi.org/10.1016/j.jacc.2023.03.419
https://doi.org/10.1016/j.jacc.2023.03.419
Autor:
Barry H. Trachtenberg, Javier Jimenez, Alanna A. Morris, Evan Kransdorf, Anjali Owens, Daniel P. Fishbein, Elizabeth Jordan, Daniel D. Kinnamon, Jonathan O. Mead, Gordon S. Huggins, Ray E. Hershberger, Garrie Haas, Daniel Fishbein, Stephen S. Gottlieb, Matthew T. Wheeler, Mark Hofmeyer, W. H. Wilson Tang, Anjali T. Owens, Charles K. Moore, Javier Jimenez Carcamo, Barry Trachtenberg, Nancy K. Sweitzer, Palak Shah, Brian Lowes, Douglas Stoller, Frank Smart, Jane Wilcox, Stuart Katz, Gregory A. Ewald, Keith D. Aaronson, Jessica J. Wang, Salpy Pamboukian, Daniel P. Judge, Evan P. Kransdorf, Sonia Garg, Patrice Desvigne-Nickens, James Troendle, Yi-Ping Fu, Lucia Hindorff
Publikováno v:
Genetics in Medicine. 24:1495-1502
The cardiac phenotype of hereditary transthyretin amyloidosis (hTTR) usually presents as a restrictive or hypertrophic cardiomyopathy, and, although rarely observed as dilated cardiomyopathy (DCM), TTR is routinely included in DCM genetic testing pan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c69ccefe6398c6715752be5ee4a6726
https://doi.org/10.1016/j.gim.2022.03.011
https://doi.org/10.1016/j.gim.2022.03.011
Publikováno v:
Current Problems in Cardiology. 48:101627
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd7f97d5907aab96f289bf6ecd4bc994
https://doi.org/10.1016/j.cpcardiol.2023.101627
https://doi.org/10.1016/j.cpcardiol.2023.101627
Publikováno v:
Journal of Cardiac Failure. 29:632
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44f38a4849f8d6f633fb4e3de619f920
https://doi.org/10.1016/j.cardfail.2022.10.211
https://doi.org/10.1016/j.cardfail.2022.10.211
Autor:
Muhannad A. Abbasi, Douglas Stoller, Elizabeth Lyden, Brian Lowes, Ronald Zolty, Scott Lundgren
Publikováno v:
Journal of Cardiac Failure. 29:632
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2ccf9f8c23e8b641956bcf017d275d53
https://doi.org/10.1016/j.cardfail.2022.10.210
https://doi.org/10.1016/j.cardfail.2022.10.210
Autor:
Gordon S, Huggins, Daniel D, Kinnamon, Garrie J, Haas, Elizabeth, Jordan, Mark, Hofmeyer, Evan, Kransdorf, Gregory A, Ewald, Alanna A, Morris, Anjali, Owens, Brian, Lowes, Douglas, Stoller, W H Wilson, Tang, Sonia, Garg, Barry H, Trachtenberg, Palak, Shah, Salpy V, Pamboukian, Nancy K, Sweitzer, Matthew T, Wheeler, Jane E, Wilcox, Stuart, Katz, Stephen, Pan, Javier, Jimenez, Keith D, Aaronson, Daniel P, Fishbein, Frank, Smart, Jessica, Wang, Stephen S, Gottlieb, Daniel P, Judge, Charles K, Moore, Jonathan O, Mead, Hanyu, Ni, Wylie, Burke, Ray E, Hershberger
Publikováno v:
JAMA. 327(5)
Idiopathic dilated cardiomyopathy (DCM) aggregates in families, and early detection in at-risk family members can provide opportunity to initiate treatment prior to late-phase disease. Most studies have included only White patients, yet Black patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::400170ed2202b9ca2390f43b126ec30f
https://pubmed.ncbi.nlm.nih.gov/35103786
https://pubmed.ncbi.nlm.nih.gov/35103786
Autor:
Arif Albulushi, Daniel Zolty, Kajari Dhar, Adam Burdorf, Douglas Stoller, Marshall Hyden, Brian Lowes, Ronald Zolty
Publikováno v:
Journal of the American College of Cardiology. 75:2103
Cyclic guanosine monophosphate (cGMP) plays an important role as pulmonary vasodilator and currently there are targeted therapy to stimulate cGMP in the management of patients with pulmonary hypertension. It is known that patients with pulmonary hype
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38dce8ff2e1411a7f1a53ca9288266c2
https://doi.org/10.1016/s0735-1097(20)32730-3
https://doi.org/10.1016/s0735-1097(20)32730-3
Autor:
Josef Stehlik, Quinn Wells, Adrian F. Hernandez, Alexandros Briasoulis, Juan Vilaro, Anuradha (Anu) Lala, Peter M. Eckman, Kurt G. Barringhaus, Ravi Dhingra, Xian Shen, Haolin Xu, Jo E. Rodgers, Emily C. O'Brien, Tamas Alexy, Marc A. Simon, Shannon M. Dunlay, Robert J. Mentz, Martha Abshire, Johana Espinoza, Brian Lowes, Rosalia Blanco, Carol I. Duffy, Laine Thomas, Bhanu Gupta
Publikováno v:
Journal of the American College of Cardiology. 75:810
PARADIGM-HF showed that sacubitril/valsartan (sac/val) improved quality of life (QOL) vs enalapril in heart failure with reduced ejection fraction (HFrEF), yet limited data are available regarding QOL changes after sac/val initiation in routine pract
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d70b23432ce13bf95c2799be23c5112
https://doi.org/10.1016/s0735-1097(20)31437-6
https://doi.org/10.1016/s0735-1097(20)31437-6
Autor:
Marshall Hyden, Scott Lundgren, John Um, Douglas Stoller, Ronald Zolty, Adam Burdorf, Elizabeth Lyden, Brian Lowes
Publikováno v:
Journal of Cardiac Failure. 25:S178-S179
Introduction Digoxin use within the heart failure population remains controversial, as studies have suggested increased arrhythmia risk and lower survival. Despite decades of use in heart failure, little is known regarding digoxin utilization post-le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57f9261c047bed94962fa84acad08cce
https://doi.org/10.1016/j.cardfail.2019.07.506
https://doi.org/10.1016/j.cardfail.2019.07.506